Table 3 Risk management before/after donepezil deployment in N2
Before | After | |||
|---|---|---|---|---|
201X.4 ~ 10 | Mean (Month) | 201X.10 ~ 201X + 3. | Mean (Month) | |
Fall | 83 | 11.9 | 38 | 7.6 |
Bruise | 6 | 0.9 | 4 | 0.8 |
Drug | 6 | 0.9 | 5 | 1.0 |
Swallow | 0 | 0 | 1 | 0.2 |
Bed | 2 | 0.3 | 0 | 0 |
Loss | 0 | 0 | 0 | 0 |
Before | After | |||
|---|---|---|---|---|
201X.4 ~ 10 | Mean (Month) | 201X.10 ~ 201X + 3. | Mean (Month) | |
Fall | 83 | 11.9 | 38 | 7.6 |
Bruise | 6 | 0.9 | 4 | 0.8 |
Drug | 6 | 0.9 | 5 | 1.0 |
Swallow | 0 | 0 | 1 | 0.2 |
Bed | 2 | 0.3 | 0 | 0 |
Loss | 0 | 0 | 0 | 0 |